Form 4: Encompass Health Director Christopher R. Reidy Reports Stock Transactions

Director Christopher R. Reidy of Encompass Health Corp. reports acquiring shares through dividend reinvestment and a deferred stock plan.

Summary

• Christopher R. Reidy, a director at Encompass Health Corp., reported acquiring 16 shares of common stock on January 15, 2025, as a result of a dividend reinvestment.
• He also acquired 375 shares on January 16, 2025, through the company's Directors Deferred Stock Investment Plan at a weighted average price of $94.38 per share.
• These transactions increased his total direct holdings to 12,632 shares.
• The dividend paid on January 15, 2025, was $0.17 per share, and the closing price on that day was $93.61.

Sentiment

Score: 7

Explanation: The document reflects routine transactions by a director, indicating a neutral to slightly positive sentiment due to the director's participation in company investment plans.

Positives

• The director's participation in the deferred stock plan indicates confidence in the company's future performance.
• Dividend reinvestment further demonstrates a long-term commitment to the company.

Industry Context

This filing is a routine disclosure of stock transactions by a company director, which is common practice in publicly traded companies. It reflects the director's personal investment decisions and participation in company benefit plans.

Comparison to Industry Standards

• The transactions are typical for directors of publicly listed companies, who often participate in deferred stock plans and dividend reinvestment programs.
• Similar filings are regularly made by directors and officers of comparable companies in the healthcare sector, such as Select Medical Holdings Corporation and Tenet Healthcare Corporation.

Stakeholder Impact

• The transactions have a minor positive impact on shareholders as they demonstrate director confidence in the company.
• The transactions have no direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Encompass Health, Director, Stock Transactions, Dividend Reinvestment, Deferred Stock Plan, SEC Form 4, Christopher R. Reidy